manual on management of drugs

More documents

Recommendations

Info

2.2 In case of major exposures: 2.2.1 To apparently healthy and observable, cats and dogs and 2.2.2 The animal has had at least minimum of 2 Rabies vaccinations with the last vaccine given within the last 1 year In such situations, the patient should be advised to observe the animal for a period of 14 days. Immediate PET should be initiated if behavioral changes or sickness develops in the animal. 3. Where ever possible, hospital authorities should take necessary action to establish special rabies treatment units with facilities to handle any emergencies arising due to administration of equine rabies immunoglobulins. 4. Separate registers must be maintained for each treatment type (serum, 1D2 site schedule, 1D 8 site schedule, 1M 2-1-1 schedule, 1M 5 dose schedule) at the Rabies treatment clinics. The relevant column should be marked with a (√ ). Format for the Register for different schedules: Type of schedules . Serial No Date Name of the patient OPD No Serum 1 st dose 2 nd dose 3 rd dose 4 th dose 5 th dose 5. all institutions using Rabies immunoglobulin and anti rabies vaccine should send a monthly return to Consultant Virologist, Dept. of Rabies and Vaccine QC, MRl, Director, Public health Veterinary Services, 6 th Floor, 555/5, Elvitigala Mw,Colombo 05 and to the Director/MSD, before collection of the next months vaccine supplies from MSD/RMSD. Please note that anti Rabies serum and vaccine stocks will not be issued if the returns are not sent in time. Heads of institutions will be responsible for any shortages of supplies due to this reason. 77
Monthly return for vaccine consumption Name of the institution…………………………………. Year ……………………Month…………………………. Type of vaccination Serum ERIG Total number of patients treated with Type of vaccination Intramuscular 5 dose schedule 2-1-1 schedule IM Total Total number of patients treated with 1 st dose 2nd dose 3rd dose 4th dose 5th dddddose dose Intradermal 2 site shedule 8 site shedule ID Total Vaccine Balance Opening Balance Received during the month Consumption Balance at the end of the month ………………….. ……………………………. …………………… Signature Designation Date Signed Dr. Ajith Mendis Director General of health Service 78
Page 2 and 3:
MANUAL ON MANAGEMENT OF DRUGS SECON
Page 4 and 5:
MESSAGE BY THE SECRETARY/ MINISTRY
Page 6 and 7:
ACKNOWLEDGEMENT It is a great pleas
Page 8 and 9:
Dr. J. M. J. Munasinghe Dr. K. C. L
Page 10 and 11:
ABBREVIATIONS AD CP CDD CDDA D(F) D
Page 12 and 13:
CONTENTS Message by the Hon. Minist
Page 14 and 15:
X Form for Drug sample for quality
Page 16 and 17:
CHAPTER 1 INTRODUCTION 1.Ensuring a
Page 18 and 19:
3.The expenditure on drugs has been
Page 20 and 21:
of poisons, opium, and dangerous dr
Page 22 and 23:
(Medical Technology & Supplies) No
Page 24 and 25:
c) NDQAL for quality assurance of d
Page 26 and 27:
Deputy Director General (Finance) D
Page 28 and 29:
(d) The Institutional Drug Therapeu
Page 30 and 31:
CHAPTER 4 ESTIMATION OF ANNUAL REQU
Page 32 and 33:
Step 2 Identify the stock available
Page 34 and 35:
In the case of institutions under t
Page 36 and 37:
oard appointed by him and a report
Page 38 and 39:
Head of the Institution may add any
Page 40 and 41:
ii. Injections costing Rs. 25.00 or
Page 42 and 43: 42. Delivery schedules are planned
Page 44 and 45: CHAPTER 6 CARE IN PRESCRIBING DRUGS
Page 46 and 47: CHAPTER 7 DISTRIBUTION AND LOGISTIC
Page 48 and 49: the institution. Records of the inv
Page 50 and 51: RMSD or institutional stores, the o
Page 52 and 53: CHAPTER 8 QUALITY ASSURANCE OF DRUG
Page 54 and 55: ioavailability. Further, in apprais
Page 56 and 57: x. Details of any preservative adde
Page 58 and 59: To request institutions to inform t
Page 60 and 61: CHAPTER 9 STORAGE OF DRUGS. 1. Prop
Page 62 and 63: xi. Storage of vaccine in the refri
Page 64 and 65: CHAPTER 10 MONITORING OF CONSUMPTIO
Page 66 and 67: ii. VEN analysis ( See annexure XV
Page 68 and 69: 9. Monitoring of quality of drugs;
Page 70 and 71: alance as per ledger, actual balanc
Page 72 and 73: 1.3 In case of institutions coming
Page 74 and 75: Ampoules should be crushed and buri
Page 76 and 77: ANNEXURE I1: Main functions of Medi
Page 78 and 79: I - Annual stock holding cost as a
Page 80 and 81: Anti Rabies cell culture vaccine. (
Page 82 and 83: unobservable (animal dead, killed,
Page 84 and 85: on D0, D3, D7, D14 & D30. 6.1.2 For
Page 86 and 87: All patients who receive rabies PET
Page 88 and 89: Monthly return for vaccine consumpt
Page 90 and 91: Death in the house / outside a Medi
Page 94 and 95: ANNEXURE - V MyNo……/…../….
Page 96 and 97: Advertisement Screening Unit Unit o
Page 98 and 99: ANNEXURE VIII (To be amended To: My
Page 100 and 101: ANNEXURE X ……………………
Page 102 and 103: 6. Quality failure of registration
Page 105 and 106: ANNEXURE XIII Lot Card SR No……
Page 107 and 108: ANNEXURE XV VEN Analysis This analy
Page 109: Sample Guidelines for VEN Category
Page 112 and 113: Unsatisfactory clinical response, a
Page 114 and 115: Local Agents of supplier (on reques
show all

manual on management of drugs

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?